Literature DB >> 8021135

Permanent iodine-125 implants in postoperative radiotherapy for head and neck cancer with positive surgical margins.

B Vikram1, S Mishra.   

Abstract

BACKGROUND: Patients with head and neck cancer treated surgically have a high local recurrence rate, unless the surgeon is able to obtain adequate margins of resection. In patients with positive margins, tumor control is suboptimal despite postoperative radiotherapy.
METHODS: We treated 25 consecutive patients, who were at high risk for local recurrence by virtue of positive margins, by modest dose postoperative external-beam irradiation (median 60 Gy) followed by elective iodine 125 (I-125) implantation.
RESULTS: With a median follow-up of 1.5 years (range 1-5 years), there were no instances of necrosis, and only one (4%) instance of a local recurrence. Six patients (24%) developed distant metastases.
CONCLUSIONS: These results indicate that elective I-125 implantation as a part of postoperative radiotherapy is safe enough for a phase III study in patients with positive margins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8021135     DOI: 10.1002/hed.2880160209

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  4 in total

1.  A novel modular polymer platform for the treatment of head and neck squamous cell carcinoma in an animal model.

Authors:  David Hu; Ontario D Lau; Linda Wang; Guanyu Wang; Dorthe Schaue; Li Zhu; Min Huang; Yuan Lin; Miranda Dennis; Elliot Abemayor; David A Elashoff; Steven M Dubinett; William H McBride; Sherven Sharma; Ben Wu; Maie A St John
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2012-04

2.  A cytokine-delivering polymer is effective in reducing tumor burden in a head and neck squamous cell carcinoma murine model.

Authors:  Yuan Lin; Jie Luo; Weichao Eric Zhu; Minu Srivastava; Dorthe Schaue; David A Elashoff; Steven M Dubinett; Sherven Sharma; Benjamin Wu; Maie A St John
Journal:  Otolaryngol Head Neck Surg       Date:  2014-05-13       Impact factor: 3.497

3.  Palliative treatment of pelvic bone tumors using radioiodine (125I) brachytherapy.

Authors:  Chongren Wang; Zhengqi Chen; Wei Sun; Yisilamu Yasin; Chuanyin Zhang; Xiaojun Ma; Jian Chen; Jiakang Shen; Yingqi Hua; Zhengdong Cai
Journal:  World J Surg Oncol       Date:  2016-11-25       Impact factor: 2.754

4.  Modular polymer platform as a novel approach to head and neck cancer therapy.

Authors:  Yazeed Alhiyari; Jundong Shao; Albert Y Han; Amanda Miller; Jeffrey F Krane; Marie Luff; Milica Momcilovic; David Shackelford; Zhen Gu; Maie A St John
Journal:  Sci Rep       Date:  2022-03-04       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.